Total Payments
$6,662
2024 Payments
$1,144
Companies
38
Transactions
356
Medicare Patients
4,369
Medicare Billing
$318,294
Payment Breakdown by Category
Food & Beverage$6,626 (99.5%)
Education$35.71 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,626 | 354 | 99.5% |
| Education | $35.71 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,944 | 116 | $0 (2024) |
| Amgen Inc. | $569.27 | 24 | $0 (2024) |
| LEO Pharma Inc. | $567.12 | 27 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $518.15 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $508.30 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $287.85 | 19 | $0 (2024) |
| Celgene Corporation | $212.19 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $194.50 | 8 | $0 (2024) |
| Lilly USA, LLC | $179.63 | 8 | $0 (2022) |
| Incyte Corporation | $172.37 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,144 | 58 | ABBVIE INC. ($338.78) |
| 2023 | $700.25 | 30 | AbbVie Inc. ($175.95) |
| 2022 | $711.58 | 37 | ABBVIE INC. ($401.45) |
| 2021 | $813.37 | 48 | AbbVie Inc. ($458.38) |
| 2020 | $571.56 | 36 | Ortho Dermatologics, a division of Bausch Health US, LLC ($137.05) |
| 2019 | $882.65 | 52 | AbbVie, Inc. ($222.13) |
| 2018 | $870.39 | 51 | Celgene Corporation ($166.30) |
| 2017 | $967.39 | 44 | Amgen Inc. ($247.22) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.61 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $39.20 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: Immunology | ||||||
| 10/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.35 | General |
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.95 | General |
| Category: Immunology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.49 | General |
| Category: Immunology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.85 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: DERMATOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.42 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), TARGRETIN | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.59 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,147 | 2,048 | $192,140 | $86,440 |
| 2022 | 12 | 1,343 | 2,262 | $223,250 | $101,837 |
| 2021 | 8 | 966 | 1,633 | $126,460 | $74,792 |
| 2020 | 6 | 913 | 1,461 | $102,530 | $55,226 |
Total Patients
4,369
Total Services
7,404
Medicare Billing
$318,294
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 446 | 641 | $76,920 | $40,841 | 53.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 117 | 141 | $25,380 | $11,824 | 46.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 197 | 265 | $33,125 | $11,490 | 34.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 80 | 93 | $13,485 | $6,825 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 46 | $7,820 | $3,884 | 49.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 135 | 708 | $17,700 | $3,579 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 93 | $7,440 | $3,543 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $7,000 | $2,838 | 40.5% |
| 10040 | Acne surgery | Office | 2023 | 12 | 12 | $1,800 | $1,055 | 58.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 14 | $1,470 | $561.51 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 513 | 705 | $84,600 | $45,119 | 53.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 150 | 179 | $32,220 | $15,156 | 47.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 231 | 332 | $41,500 | $13,958 | 33.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 82 | 100 | $14,500 | $7,959 | 54.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $11,400 | $4,497 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 40 | $6,800 | $3,944 | 58.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 152 | 721 | $18,025 | $3,788 | 21.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 65 | 72 | $5,760 | $2,999 | 52.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 18 | 18 | $3,060 | $1,939 | 63.4% |
| 10040 | Acne surgery | Office | 2022 | 13 | 13 | $1,950 | $1,170 | 60.0% |
| 69100 | Biopsy of ear | Office | 2022 | 11 | 12 | $1,680 | $882.83 | 52.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $1,755 | $424.88 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 457 | 649 | $64,080 | $42,058 | 65.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 177 | 244 | $21,960 | $11,175 | 50.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 96 | 114 | $17,100 | $9,769 | 57.1% |
About Dr. Michael Bharier, MD
Dr. Michael Bharier, MD is a Dermatology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336145135.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bharier, MD has received a total of $6,662 in payments from pharmaceutical and medical device companies, with $1,144 received in 2024. These payments were reported across 356 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,626).
As a Medicare-enrolled provider, Bharier has provided services to 4,369 Medicare beneficiaries, totaling 7,404 services with total Medicare billing of $318,294. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Cranston, RI
- Active Since 06/27/2005
- Last Updated 02/15/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336145135
Products in Payments
- SKYRIZI (Biological) $558.48
- RINVOQ (Biological) $553.75
- COSENTYX (Biological) $429.09
- HUMIRA (Biological) $382.31
- Enbrel (Biological) $336.40
- ADBRY (Biological) $316.70
- Otezla (Drug) $288.42
- Sotyktu (Drug) $287.85
- Humira (Biological) $261.31
- DUOBRII (Drug) $254.61
- ENSTILAR (Drug) $250.42
- TALTZ (Drug) $179.63
- Skyrizi (Biological) $174.49
- OPZELURA (Drug) $172.37
- DORYX (Drug) $155.15
- Cimzia (Drug) $154.62
- TREMFYA (Drug) $110.00
- ONEXTON (Drug) $94.55
- REMICADE (Biological) $84.50
- DUPIXENT (Biological) $84.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.